AkzoNobel Q2 2026: Adjusted EBITDA margin expands to 15.4%, full-year guidance raised to ≥€1.47B, and Russian entities seized
AKZOF sits 26% above its 52-week low of $53.63.
Summary
AkzoNobel reported Q2 2026 margin expansion and raised full-year guidance, but disclosed that its Russian entities were seized by presidential decree, forcing deconsolidation and a €49M translation loss.
Key Events · Earnings and Guidance · AKZOF
-
Q2 2026 Earnings Beat
Organic sales grew 2% on pricing, while adjusted EBITDA rose to €398M and the margin expanded to 15.4% from 15.0% a year ago. Operating income increased 17% to €251M.
-
Full-Year Guidance Raised
Driven by pricing and industrial excellence programs, management now expects full-year 2026 adjusted EBITDA at or above €1.47 billion, up from prior expectations.
-
Russian Entities Seized
A July 13, 2026 presidential decree placed AkzoNobel's Russian entities under temporary external administration. The company will deconsolidate these operations, resulting in a €49M cumulative translation loss and removal of €214M in net assets.
-
Axalta Merger Progress
An Extraordinary General Meeting of shareholders to vote on the all-stock Axalta merger is scheduled for August 5, 2026. Closing remains expected in late 2026 or early 2027.
Analysis · AKZOF · Industrial Applications And Services
A solid Q2 saw organic sales rise 2% on pricing, lifting the adjusted EBITDA margin to 15.4% and prompting management to raise full-year 2026 adjusted EBITDA guidance to at or above €1.47 billion—a clear signal of confidence in sustained profitability. Offsetting this, a subsequent event introduces fresh geopolitical risk: on July 13, 2026, a presidential decree placed the company's Russian entities under temporary external administration. While those operations account for less than 2% of revenue, deconsolidation will trigger a €49 million cumulative translation loss and remove €214 million in net assets from the balance sheet. Meanwhile, the Axalta merger remains on track, with a shareholder vote set for August 5, 2026.
At the time of this filing, AKZOF was trading at $67.50 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $11.5B. The 52-week trading range was $53.63 to $131.37. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.